{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:36:38Z","timestamp":1794587798201,"version":"4.9.1"},"reference-count":285,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82160690"],"award-info":[{"award-number":["No. 82160690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Science and Technology Foundation of Guizhou Province","doi-asserted-by":"crossref","award":["No. ZK [2021]-014"],"award-info":[{"award-number":["No. ZK [2021]-014"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Collaborative Innovation Center of Chinese Ministry of Education","award":["No. 2020-39"],"award-info":[{"award-number":["No. 2020-39"]}],"id":[{"id":"https:\/\/ror.org\/03m01yf64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The microbiota\u2013gut\u2013brain axis (MGBA) is an intricate bidirectional communication network that links intestinal microbiota with the central nervous system (CNS) through immune, neural, endocrine, and metabolic pathways. Emerging evidence suggests that dysregulation of the MGBA plays pivotal roles in the onset and progression of neurodegenerative diseases. This review outlines the key molecular mechanisms by which gut microbes modulate neuroinflammation, blood\u2013brain barrier integrity, protein misfolding, and neuronal homeostasis. We discuss how microbial metabolites, such as short-chain fatty acids, tryptophan derivatives, and bile acids, interact with host to influence CNS functions. Disease-specific features are described across Alzheimer\u2019s disease, Parkinson\u2019s disease, Multiple sclerosis, and Amyotrophic lateral sclerosis, emphasizing the distinct and overlapping pathways through which gut dysbiosis may contribute to pathogenesis. We further explore the translational potential of microbiota-targeted therapies, including probiotics, fecal microbiota transplantation, dietary interventions, and small-molecule modulators. While preclinical results are promising, clinical trials reveal considerable variability, highlighting the need for personalized approaches and robust biomarkers. Challenges remain in deciphering causal relationships, accounting for inter-individual variability, and ensuring reproducibility in therapeutic outcomes. Future research should integrate multi-omics strategies, longitudinal human cohorts, and mechanistic models to clarify the role of the MGBA in neurodegeneration. Collectively, understanding the MGBA provides a transformative perspective on neurodegenerative disease mechanisms and offers innovative therapeutic avenues that bridge neurology, microbiology, and precision medicine.<\/jats:p>","DOI":"10.1186\/s43556-025-00307-1","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:14:29Z","timestamp":1757920469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Microbiota\u2013gut\u2013brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets"],"prefix":"10.1186","volume":"6","author":[{"given":"Ce","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-di","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-3640","authenticated-orcid":false,"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"issue":"4","key":"307_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson III","year":"2023","unstructured":"Wilson DM III, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2022.12.032.","journal-title":"Cell"},{"issue":"1","key":"307_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31873-5","volume":"13","author":"TS Wingo","year":"2022","unstructured":"Wingo TS, Liu Y, Gerasimov ES, Vattathil SM, Wynne ME, Liu J, et al. Shared mechanisms across the major psychiatric and neurodegenerative diseases. Nat Commun. 2022;13(1):4314. https:\/\/doi.org\/10.1038\/s41467-022-31873-5.","journal-title":"Nat Commun"},{"issue":"6","key":"307_CR3","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810248","volume":"11","author":"S Voet","year":"2019","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 2019;11(6):e10248. https:\/\/doi.org\/10.15252\/emmm.201810248.","journal-title":"EMBO Mol Med"},{"issue":"6571","key":"307_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1126\/science.abi6087","volume":"374","author":"G Agirman","year":"2021","unstructured":"Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the gut-brain axis. Science. 2021;374(6571):1087\u201392. https:\/\/doi.org\/10.1126\/science.abi6087.","journal-title":"Science"},{"key":"307_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143771","author":"M Camilleri","year":"2021","unstructured":"Camilleri M. Gastrointestinal motility disorders in neurologic disease. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI143771.","journal-title":"J Clin Invest"},{"issue":"1","key":"307_CR6","doi-asserted-by":"publisher","first-page":"e00338","DOI":"10.1128\/CMR.00338-20","volume":"35","author":"SG Sorboni","year":"2022","unstructured":"Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin Microbiol Rev. 2022;35(1):e00338\u2013e420. https:\/\/doi.org\/10.1128\/CMR.00338-20.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"307_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gtc.2016.09.007","volume":"46","author":"TG Dinan","year":"2017","unstructured":"Dinan TG, Cryan JF. The microbiome-gut-brain axis in health and disease. Gastroenterol Clin North Am. 2017;46(1):77\u201389. https:\/\/doi.org\/10.1016\/j.gtc.2016.09.007.","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"307_CR8","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","volume":"160","author":"KG Margolis","year":"2021","unstructured":"Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology. 2021;160(5):1486\u2013501. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.066.","journal-title":"Gastroenterology"},{"key":"307_CR9","doi-asserted-by":"publisher","unstructured":"Agirman G, Hsiao EY. SnapShot: The microbiota-gut-brain axis. Cell. 2021; 184(9): 2524\u20132524. e1. https:\/\/doi.org\/10.1016\/j.cell.2021.03.022.","DOI":"10.1016\/j.cell.2021.03.022"},{"issue":"1","key":"307_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther. 2024;9(1):37. https:\/\/doi.org\/10.1038\/s41392-024-01743-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"307_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/procel\/pwad026","volume":"14","author":"Q Wang","year":"2023","unstructured":"Wang Q, Yang Q, Liu X. The microbiota\u2013gut\u2013brain axis and neurodevelopmental disorders. Protein Cell. 2023;14(10):762\u201375. https:\/\/doi.org\/10.1093\/procel\/pwad026.","journal-title":"Protein Cell"},{"issue":"8","key":"307_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.656","volume":"5","author":"M You","year":"2024","unstructured":"You M, Chen N, Yang Y, Cheng L, He H, Cai Y, et al. The gut microbiota\u2013brain axis in neurological disorders. MedComm. 2024;5(8):e656. https:\/\/doi.org\/10.1002\/mco2.656.","journal-title":"MedComm"},{"issue":"4","key":"307_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","volume":"19","author":"LH Morais","year":"2021","unstructured":"Morais LH, Schreiber HL IV, Mazmanian SK. The gut microbiota\u2013brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2021;19(4):241\u201355. https:\/\/doi.org\/10.1038\/s41579-020-00460-0.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"307_CR14","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/cphy.c140065","volume":"5","author":"M Keller-Wood","year":"2015","unstructured":"Keller-Wood M. Hypothalamic-pituitary-adrenal Axis\u2014feedback control. Compr Physiol. 2015;5(3):1161\u201382. https:\/\/doi.org\/10.1002\/cphy.c140065.","journal-title":"Compr Physiol"},{"issue":"1","key":"307_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135. https:\/\/doi.org\/10.1038\/s41392-022-00974-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"307_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.biopsych.2023.10.014","volume":"95","author":"AA Madison","year":"2024","unstructured":"Madison AA, Bailey MT. Stressed to the core: inflammation and intestinal permeability link stress-related gut microbiota shifts to mental health outcomes. Biol Psychiatry. 2024;95(4):339\u201347. https:\/\/doi.org\/10.1016\/j.biopsych.2023.10.014.","journal-title":"Biol Psychiatry"},{"key":"307_CR17","doi-asserted-by":"publisher","unstructured":"Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology. 2017;152(2): 327\u2013339. e4. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.012.","DOI":"10.1053\/j.gastro.2016.10.012"},{"issue":"9","key":"307_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2018.04.002","volume":"39","author":"JM Allaire","year":"2018","unstructured":"Allaire JM, Crowley SM, Law HT, Chang SY, Ko HJ, Vallance BA. The intestinal epithelium: central coordinator of mucosal immunity. Trends Immunol. 2018;39(9):677\u201396. https:\/\/doi.org\/10.1016\/j.it.2018.04.002.","journal-title":"Trends Immunol"},{"issue":"4","key":"307_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41385-021-00389-4","volume":"14","author":"UM M\u00f6rbe","year":"2021","unstructured":"M\u00f6rbe UM, J\u00f8rgensen PB, Fenton TM, von Burg N, Riis LB, Spencer J, et al. Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunol. 2021;14(4):793\u2013802. https:\/\/doi.org\/10.1038\/s41385-021-00389-4.","journal-title":"Mucosal Immunol"},{"issue":"5","key":"307_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","volume":"9","author":"JB Furness","year":"2012","unstructured":"Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9(5):286\u201394. https:\/\/doi.org\/10.1038\/nrgastro.2012.32.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6_suppl_4","key":"307_CR21","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1212\/WNL.59.6_suppl_4.S3","volume":"59","author":"TR Henry","year":"2002","unstructured":"Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology. 2002;59(6_suppl_4):S3\u201314. https:\/\/doi.org\/10.1212\/WNL.59.6_suppl_4.S3.","journal-title":"Neurology"},{"key":"307_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-018-0476-7","volume":"25","author":"MM Pusceddu","year":"2018","unstructured":"Pusceddu MM, Gareau MG. Visceral pain: gut microbiota, a new hope? J Biomed Sci. 2018;25:1\u20138. https:\/\/doi.org\/10.1186\/s12929-018-0476-7.","journal-title":"J Biomed Sci"},{"key":"307_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbi.2018.07.007","volume":"73","author":"M Vodi\u010dka","year":"2018","unstructured":"Vodi\u010dka M, Ergang P, Hrn\u010d\u00ed\u0159 T, Mikuleck\u00e1 A, Kvapilov\u00e1 P, Vagnerov\u00e1 K, et al. Microbiota affects the expression of genes involved in HPA axis regulation and local metabolism of glucocorticoids in chronic psychosocial stress. Brain Behav Immun. 2018;73:615\u201324. https:\/\/doi.org\/10.1016\/j.bbi.2018.07.007.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"307_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1084\/jem.20180794","volume":"216","author":"R Abdel-Haq","year":"2019","unstructured":"Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK. Microbiome-microglia connections via the gut-brain axis. J Exp Med. 2019;216(1):41\u201359. https:\/\/doi.org\/10.1084\/jem.20180794.","journal-title":"J Exp Med"},{"key":"307_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143768","author":"MD Gershon","year":"2021","unstructured":"Gershon MD, Margolis KG. The gut, its microbiome, and the brain: connections and communications. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI143768.","journal-title":"J Clin Invest"},{"key":"307_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101982","author":"KJ O\u2019Riordan","year":"2025","unstructured":"O\u2019Riordan KJ, Moloney GM, Keane L, Clarke G, Cryan JF. The gut microbiota-immune-brain axis: therapeutic implications. Cell Rep Med. 2025. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101982.","journal-title":"Cell Rep Med"},{"issue":"4","key":"307_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuron.2021.12.020","volume":"110","author":"SL Prescott","year":"2022","unstructured":"Prescott SL, Liberles SD. Internal senses of the vagus nerve. Neuron. 2022;110(4):579\u201399. https:\/\/doi.org\/10.1016\/j.neuron.2021.12.020.","journal-title":"Neuron"},{"issue":"7","key":"307_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3345\/cep.2021.01550","volume":"66","author":"GH Kim","year":"2023","unstructured":"Kim GH, Shim JO. Gut microbiota affects brain development and behavior. Clin Exp Pediatr. 2023;66(7):274\u201380. https:\/\/doi.org\/10.3345\/cep.2021.01550.","journal-title":"Clin Exp Pediatr"},{"key":"307_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01007-y","volume":"9","author":"Y Jing","year":"2021","unstructured":"Jing Y, Yu Y, Bai F, Wang L, Yang D, Zhang C, et al. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis. Microbiome. 2021;9:1\u201321. https:\/\/doi.org\/10.1186\/s40168-021-01007-y.","journal-title":"Microbiome"},{"key":"307_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01165-z","volume":"9","author":"FA Vicentini","year":"2021","unstructured":"Vicentini FA, Keenan CM, Wallace LE, Woods C, Cavin JB, Flockton AR, et al. Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. Microbiome. 2021;9:1\u201324. https:\/\/doi.org\/10.1186\/s40168-021-01165-z.","journal-title":"Microbiome"},{"issue":"12","key":"307_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92295","volume":"2","author":"R Chandra","year":"2017","unstructured":"Chandra R, Hiniker A, Kuo YM, Nussbaum RL, Liddle RA. \u03b1-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease. JCI Insight. 2017;2(12):e92295. https:\/\/doi.org\/10.1172\/jci.insight.92295.","journal-title":"JCI Insight"},{"issue":"21","key":"307_CR32","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"B Liu","year":"2017","unstructured":"Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, et al. Vagotomy and Parkinson disease: a Swedish register\u2013based matched-cohort study. Neurology. 2017;88(21):1996\u20132002. https:\/\/doi.org\/10.1212\/WNL.0000000000003961.","journal-title":"Neurology"},{"issue":"4","key":"307_CR33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78(4):522\u20139. https:\/\/doi.org\/10.1002\/ana.24448.","journal-title":"Ann Neurol"},{"issue":"4","key":"307_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","volume":"46","author":"Y Belkaid","year":"2017","unstructured":"Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017;46(4):562\u201376. https:\/\/doi.org\/10.1016\/j.immuni.2017.04.008.","journal-title":"Immunity"},{"issue":"3","key":"307_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4161\/gmic.29330","volume":"5","author":"MB Geuking","year":"2014","unstructured":"Geuking MB, K\u00f6ller Y, Rupp S, McCoy KD. The interplay between the gut microbiota and the immune system. Gut Microbes. 2014;5(3):411\u20138. https:\/\/doi.org\/10.4161\/gmic.29330.","journal-title":"Gut Microbes"},{"key":"307_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104714","volume":"136","author":"TC Fung","year":"2020","unstructured":"Fung TC. The microbiota-immune axis as a central mediator of gut-brain communication. Neurobiol Dis. 2020;136:104714. https:\/\/doi.org\/10.1016\/j.nbd.2019.104714.","journal-title":"Neurobiol Dis"},{"key":"307_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9:1\u201327. https:\/\/doi.org\/10.1186\/s40168-021-01107-9.","journal-title":"Microbiome"},{"issue":"3","key":"307_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41385-020-00368-1","volume":"14","author":"A Jacobson","year":"2021","unstructured":"Jacobson A, Yang D, Vella M, Chiu IM. The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes. Mucosal Immunol. 2021;14(3):555\u201365. https:\/\/doi.org\/10.1038\/s41385-020-00368-1.","journal-title":"Mucosal Immunol"},{"issue":"56","key":"307_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaz6563","volume":"6","author":"T Regen","year":"2021","unstructured":"Regen T, Isaac S, Amorim A, N\u00fa\u00f1ez NG, Hauptmann J, Shanmugavadivu A, et al. IL-17 controls central nervous system autoimmunity through the intestinal microbiome. Sci Immunol. 2021;6(56):eaaz6563. https:\/\/doi.org\/10.1126\/sciimmunol.aaz6563.","journal-title":"Sci Immunol"},{"issue":"1","key":"307_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05901-2","volume":"9","author":"M Sun","year":"2018","unstructured":"Sun M, Wu W, Chen L, Yang W, Huang X, Ma C, et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun. 2018;9(1):3555. https:\/\/doi.org\/10.1038\/s41467-018-05901-2.","journal-title":"Nat Commun"},{"key":"307_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915218","volume":"13","author":"HX Du","year":"2022","unstructured":"Du HX, Yue SY, Niu D, Liu C, Zhang LG, Chen J, et al. Gut microflora modulates Th17\/Treg cell differentiation in experimental autoimmune prostatitis via the short-chain fatty acid propionate. Front Immunol. 2022;13:915218. https:\/\/doi.org\/10.3389\/fimmu.2022.915218.","journal-title":"Front Immunol"},{"key":"307_CR42","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00018.2018","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CS, Sandhu KV, Bastiaanssen TF, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019. https:\/\/doi.org\/10.1152\/physrev.00018.2018.","journal-title":"Physiol Rev"},{"issue":"7121","key":"307_CR43","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nature05484","volume":"444","author":"KG Murphy","year":"2006","unstructured":"Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature. 2006;444(7121):854\u20139. https:\/\/doi.org\/10.1038\/nature05484.","journal-title":"Nature"},{"issue":"1","key":"307_CR44","doi-asserted-by":"publisher","first-page":"2102878","DOI":"10.1080\/19490976.2022.2102878","volume":"14","author":"H Ahmed","year":"2022","unstructured":"Ahmed H, Leyrolle Q, Koistinen V, K\u00e4rkk\u00e4inen O, Lay\u00e9 S, Delzenne N, et al. Microbiota-derived metabolites as drivers of gut\u2013brain communication. Gut Microbes. 2022;14(1):2102878. https:\/\/doi.org\/10.1080\/19490976.2022.2102878.","journal-title":"Gut Microbes"},{"key":"307_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2022.102826","volume":"78","author":"BA Everett","year":"2022","unstructured":"Everett BA, Tran P, Prindle A. Toward manipulating serotonin signaling via the microbiota\u2013gut\u2013brain axis. Curr Opin Biotechnol. 2022;78:102826. https:\/\/doi.org\/10.1016\/j.copbio.2022.102826.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"307_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02175-2","volume":"18","author":"LM Chen","year":"2021","unstructured":"Chen LM, Bao CH, Wu Y, Liang SH, Wang D, Wu LY, et al. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J Neuroinflammation. 2021;18(1):135. https:\/\/doi.org\/10.1186\/s12974-021-02175-2.","journal-title":"J Neuroinflammation"},{"key":"307_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01365","volume":"13","author":"H Kaur","year":"2019","unstructured":"Kaur H, Bose C, Mande SS. Tryptophan metabolism by gut microbiome and gut-brain-axis: an in silico analysis. Front Neurosci. 2019;13:493713. https:\/\/doi.org\/10.3389\/fnins.2019.01365.","journal-title":"Front Neurosci"},{"issue":"3","key":"307_CR48","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1172\/JCI76304","volume":"125","author":"EA Mayer","year":"2015","unstructured":"Mayer EA, Tillisch K, Gupta A. Gut\/brain axis and the microbiota. J Clin Invest. 2015;125(3):926\u201338. https:\/\/doi.org\/10.1172\/JCI76304.","journal-title":"J Clin Invest"},{"issue":"2","key":"307_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","volume":"11","author":"A Parker","year":"2020","unstructured":"Parker A, Fonseca S, Carding SR. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes. 2020;11(2):135\u201357. https:\/\/doi.org\/10.1080\/19490976.2019.1638722.","journal-title":"Gut Microbes"},{"issue":"9","key":"307_CR50","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2174\/1871527320666211119122150","volume":"21","author":"RR Kumar","year":"2022","unstructured":"Kumar RR, Singh L, Thakur A, Singh S, Kumar B. Role of vitamins in neurodegenerative diseases: a review. CNS Neurol Disord Drug Targets. 2022;21(9):766\u201373. https:\/\/doi.org\/10.2174\/1871527320666211119122150.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"5","key":"307_CR51","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/brain\/awae413","volume":"148","author":"D Belelli","year":"2024","unstructured":"Belelli D, Lambert JJ, Wan MLY, Monteiro AR, Nutt DJ, Swinny JD. From bugs to brain: unravelling the GABA signalling networks in the brain\u2013gut\u2013microbiome axis. Brain. 2024;148(5):1479\u2013506. https:\/\/doi.org\/10.1093\/brain\/awae413.","journal-title":"Brain"},{"issue":"2","key":"307_CR52","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/brv.12812","volume":"97","author":"A Glinert","year":"2022","unstructured":"Glinert A, Turjeman S, Elliott E, Koren O. Microbes, metabolites and (synaptic) malleability, oh my! The effect of the microbiome on synaptic plasticity. Biol Rev. 2022;97(2):582\u201399. https:\/\/doi.org\/10.1111\/brv.12812.","journal-title":"Biol Rev"},{"issue":"10","key":"307_CR53","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332\u201340. https:\/\/doi.org\/10.1038\/s41593-018-0235-9.","journal-title":"Nat Neurosci"},{"key":"307_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638867","volume":"12","author":"AL Miller","year":"2021","unstructured":"Miller AL, Bessho S, Grando K, T\u00fckel \u00c7. Microbiome or infections: amyloid-containing biofilms as a trigger for complex human diseases. Front Immunol. 2021;12:638867. https:\/\/doi.org\/10.3389\/fimmu.2021.638867.","journal-title":"Front Immunol"},{"issue":"1","key":"307_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01442-3","volume":"8","author":"M You","year":"2023","unstructured":"You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S, et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):196. https:\/\/doi.org\/10.1038\/s41392-023-01442-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"307_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-02001-w","volume":"13","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang C, Yuan B, Liu L, Zhang H, Zhu M, et al. Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer\u2019s disease pathologic process via GPR41 and GPR43. Microbiome. 2025;13(1):16. https:\/\/doi.org\/10.1186\/s40168-024-02001-w.","journal-title":"Microbiome"},{"issue":"1","key":"307_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"307_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70168","volume":"6","author":"Y Shen","year":"2025","unstructured":"Shen Y, Fan N, Ma SX, Cheng X, Yang X, Wang G. Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy. MedComm. 2025;6(5):e70168. https:\/\/doi.org\/10.1002\/mco2.70168.","journal-title":"MedComm"},{"issue":"6","key":"307_CR59","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341\u201352. https:\/\/doi.org\/10.1038\/nri.2016.42.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"307_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00722-y","volume":"19","author":"GC Brown","year":"2024","unstructured":"Brown GC, Heneka MT. The endotoxin hypothesis of Alzheimer\u2019s disease. Mol Neurodegener. 2024;19(1):30. https:\/\/doi.org\/10.1186\/s13024-024-00722-y.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"307_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1564-7","volume":"16","author":"GC Brown","year":"2019","unstructured":"Brown GC. The endotoxin hypothesis of neurodegeneration. J Neuroinflammation. 2019;16(1):180. https:\/\/doi.org\/10.1186\/s12974-019-1564-7.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"307_CR62","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12974-015-0291-y","volume":"12","author":"A Nazem","year":"2015","unstructured":"Nazem A, Sankowski R, Bacher M, Al-Abed Y. Rodent models of neuroinflammation for Alzheimer\u2019s disease. J Neuroinflammation. 2015;12(1):74. https:\/\/doi.org\/10.1186\/s12974-015-0291-y.","journal-title":"J Neuroinflammation"},{"key":"307_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2013.09.015","volume":"35","author":"M Schedlowski","year":"2014","unstructured":"Schedlowski M, Engler H, Grigoleit JS. Endotoxin-induced experimental systemic inflammation in humans: a model to disentangle immune-to-brain communication. Brain Behav Immun. 2014;35:1\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2013.09.015.","journal-title":"Brain Behav Immun"},{"issue":"7837","key":"307_CR64","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","volume":"588","author":"J Schluter","year":"2020","unstructured":"Schluter J, Peled JU, Taylor BP, Markey KA, Smith M, Taur Y, et al. The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020;588(7837):303\u20137. https:\/\/doi.org\/10.1038\/s41586-020-2971-8.","journal-title":"Nature"},{"issue":"27","key":"307_CR65","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1073\/pnas.0909122107","volume":"107","author":"JL Round","year":"2010","unstructured":"Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107(27):12204\u20139. https:\/\/doi.org\/10.1073\/pnas.0909122107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8009","key":"307_CR66","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41586-024-07251-0","volume":"628","author":"Y Gu","year":"2024","unstructured":"Gu Y, Bartolom\u00e9-Casado R, Xu C, Bertocchi A, Janney A, Heuberger C, et al. Immune microniches shape intestinal Treg function. Nature. 2024;628(8009):854\u201362. https:\/\/doi.org\/10.1038\/s41586-024-07251-0.","journal-title":"Nature"},{"issue":"7","key":"307_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700492","volume":"3","author":"I Cosorich","year":"2017","unstructured":"Cosorich I, Dalla-Costa G, Sorini C, Ferrarese R, Messina MJ, Dolpady J, et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv. 2017;3(7):e1700492. https:\/\/doi.org\/10.1126\/sciadv.1700492.","journal-title":"Sci Adv"},{"issue":"10","key":"307_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102647","volume":"19","author":"T Moser","year":"2020","unstructured":"Moser T, Akg\u00fcn K, Proschmann U, Sellner J, Ziemssen T. The role of TH17 cells in multiple sclerosis: therapeutic implications. Autoimmun Rev. 2020;19(10):102647. https:\/\/doi.org\/10.1016\/j.autrev.2020.102647.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"307_CR69","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485\u201398. https:\/\/doi.org\/10.1016\/j.cell.2009.09.033.","journal-title":"Cell"},{"key":"307_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108273","volume":"239","author":"T Ikeda","year":"2022","unstructured":"Ikeda T, Nishida A, Yamano M, Kimura I. Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases. Pharmacol Ther. 2022;239:108273. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108273.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"307_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00522-2","volume":"17","author":"D Bairamian","year":"2022","unstructured":"Bairamian D, Sha S, Rolhion N, Sokol H, Doroth\u00e9e G, Lemere CA, et al. Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer\u2019s disease. Mol Neurodegener. 2022;17(1):19. https:\/\/doi.org\/10.1186\/s13024-022-00522-2.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"307_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9(1):3294. https:\/\/doi.org\/10.1038\/s41467-018-05470-4.","journal-title":"Nat Commun"},{"issue":"8","key":"307_CR73","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41575-021-00430-8","volume":"18","author":"B Stockinger","year":"2021","unstructured":"Stockinger B, Shah K, Wincent E. Ahr in the intestinal microenvironment: safeguarding barrier function. Nat Rev Gastroenterol Hepatol. 2021;18(8):559\u201370. https:\/\/doi.org\/10.1038\/s41575-021-00430-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"307_CR74","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2013.01.005","volume":"34","author":"P van Baarlen","year":"2013","unstructured":"van Baarlen P, Wells JM, Kleerebezem M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol. 2013;34(5):208\u201315. https:\/\/doi.org\/10.1016\/j.it.2013.01.005.","journal-title":"Trends Immunol"},{"issue":"8","key":"307_CR75","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461\u201378. https:\/\/doi.org\/10.1038\/s41575-019-0157-3.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"307_CR76","doi-asserted-by":"publisher","unstructured":"Alpino Gd C\u00c1, Pereira-Sol GA, Dias Md Me, Aguiar ASd, Peluzio Md CG. Beneficial effects of butyrate on brain functions: A view of epigenetic. Crit Rev Food Sci Nutr. 2024;64(12):3961\u20133970. https:\/\/doi.org\/10.1080\/10408398.2022.2137776.","DOI":"10.1080\/10408398.2022.2137776"},{"issue":"17","key":"307_CR77","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111515","volume":"42","author":"J Xie","year":"2023","unstructured":"Xie J, Bruggeman A, De Nolf C, Vandendriessche C, Van Imschoot G, Van Wonterghem E, et al. Gut microbiota regulates blood-cerebrospinal fluid barrier function and A\u03b2 pathology. EMBO J. 2023;42(17):e111515. https:\/\/doi.org\/10.15252\/embj.2022111515.","journal-title":"EMBO J"},{"key":"307_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114736","author":"W Wang","year":"2024","unstructured":"Wang W, Dernst A, Martin B, Lorenzi L, Cadefau-Fabregat M, Phulphagar K, et al. Butyrate and propionate are microbial danger signals that activate the NLRP3 inflammasome in human macrophages upon TLR stimulation. Cell Rep. 2024. https:\/\/doi.org\/10.1016\/j.celrep.2024.114736.","journal-title":"Cell Rep"},{"issue":"1","key":"307_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-022-00404-0","volume":"9","author":"YL Wu","year":"2022","unstructured":"Wu YL, Zhang CH, Teng Y, Pan Y, Liu NC, Liu PX, et al. Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles. Mil Med Res. 2022;9(1):46. https:\/\/doi.org\/10.1186\/s40779-022-00404-0.","journal-title":"Mil Med Res"},{"issue":"1","key":"307_CR80","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2172671","volume":"15","author":"AB Larabi","year":"2023","unstructured":"Larabi AB, Masson HL, B\u00e4umler AJ. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023;15(1):2172671. https:\/\/doi.org\/10.1080\/19490976.2023.2172671.","journal-title":"Gut Microbes"},{"issue":"1","key":"307_CR81","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/1541-4337.12401","volume":"18","author":"N Ma","year":"2019","unstructured":"Ma N, Ma X. Dietary amino acids and the gut-microbiome-immune axis: physiological metabolism and therapeutic prospects. Compr Rev Food Sci Food Saf. 2019;18(1):221\u201342. https:\/\/doi.org\/10.1111\/1541-4337.12401.","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"2","key":"307_CR82","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/gutjnl-2018-316155","volume":"68","author":"Y Heianza","year":"2019","unstructured":"Heianza Y, Sun D, Li X, DiDonato JA, Bray GA, Sacks FM, et al. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS lost trial. Gut. 2019;68(2):263\u201370. https:\/\/doi.org\/10.1136\/gutjnl-2018-316155.","journal-title":"Gut"},{"issue":"7770","key":"307_CR83","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572(7770):474\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1443-5.","journal-title":"Nature"},{"issue":"1","key":"307_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00694-5","volume":"18","author":"KC Paul","year":"2023","unstructured":"Paul KC, Zhang K, Walker DI, Sinsheimer J, Yu Y, Kusters C, et al. Untargeted serum metabolomics reveals novel metabolite associations and disruptions in amino acid and lipid metabolism in Parkinson\u2019s disease. Mol Neurodegener. 2023;18(1):100. https:\/\/doi.org\/10.1186\/s13024-023-00694-5.","journal-title":"Mol Neurodegener"},{"issue":"14","key":"307_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146992","volume":"26","author":"HY Huang","year":"2025","unstructured":"Huang HY, Tsao SP, Yeh TH. Branched-chain amino acids in Parkinson\u2019s disease: molecular mechanisms and therapeutic potential. Int J Mol Sci. 2025;26(14):6992. https:\/\/doi.org\/10.3390\/ijms26146992.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"307_CR86","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2447824","volume":"17","author":"W Qing","year":"2025","unstructured":"Qing W, Chen H, Ma X, Chen J, Le Y, Chen H, et al. Gut dysbiosis-induced vitamin B6 metabolic disorder contributes to chronic stress-related abnormal behaviors in a cortisol-independent manner. Gut Microbes. 2025;17(1):2447824. https:\/\/doi.org\/10.1080\/19490976.2024.2447824.","journal-title":"Gut Microbes"},{"issue":"1","key":"307_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02794-5","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang J, Hodes GE, Zhang H, Zhang S, Zhao W, Golden SA, et al. Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice. Nat Commun. 2018;9(1):477. https:\/\/doi.org\/10.1038\/s41467-017-02794-5.","journal-title":"Nat Commun"},{"key":"307_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2025.2529238","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Dai J, Wang M, Yan C, Xiu M, Qu M. Alterations in gut microbiota and plasma metabolites in patients with generalized anxiety disorder: a multi-omics study. Int J Neurosci. 2025;16:1\u201318. https:\/\/doi.org\/10.1080\/00207454.2025.2529238.","journal-title":"Int J Neurosci"},{"issue":"5556","key":"307_CR89","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1067484","volume":"295","author":"MR Chapman","year":"2002","unstructured":"Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science. 2002;295(5556):851\u20135. https:\/\/doi.org\/10.1126\/science.1067484.","journal-title":"Science"},{"issue":"1","key":"307_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48309-x","volume":"15","author":"A Fern\u00e1ndez-Calvet","year":"2024","unstructured":"Fern\u00e1ndez-Calvet A, Matilla-Cuenca L, Izco M, Navarro S, Serrano M, Ventura S, et al. Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration. Nat Commun. 2024;15(1):4150. https:\/\/doi.org\/10.1038\/s41467-024-48309-x.","journal-title":"Nat Commun"},{"issue":"34","key":"307_CR91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106504118","volume":"118","author":"C Wang","year":"2021","unstructured":"Wang C, Lau CY, Ma F, Zheng C. Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration. Proc Natl Acad Sci U S A. 2021;118(34):e2106504118. https:\/\/doi.org\/10.1073\/pnas.2106504118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"307_CR92","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.chom.2020.06.008","volume":"28","author":"P Fang","year":"2020","unstructured":"Fang P, Kazmi S, Jameson K, Hsiao E. The microbiome as a modifier of neurodegenerative disease risk. Cell Host Microbe. 2020;28(2):201\u201322. https:\/\/doi.org\/10.1016\/j.chom.2020.06.008.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"307_CR93","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.chom.2020.06.008","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13(1):21. https:\/\/doi.org\/10.1016\/j.chom.2020.06.008.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"307_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00628-1","volume":"18","author":"Y Singh","year":"2023","unstructured":"Singh Y, Trautwein C, Romani J, Salker MS, Neckel PH, Fraccaroli I, et al. Overexpression of human alpha-Synuclein leads to dysregulated microbiome\/metabolites with ageing in a rat model of Parkinson disease. Mol Neurodegener. 2023;18(1):44. https:\/\/doi.org\/10.1186\/s13024-023-00628-1.","journal-title":"Mol Neurodegener"},{"key":"307_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113865","author":"C Wang","year":"2024","unstructured":"Wang C, Yang M, Liu D, Zheng C. Metabolic rescue of \u03b1-synuclein-induced neurodegeneration through propionate supplementation and intestine-neuron signaling in C. elegans. Cell Rep. 2024. https:\/\/doi.org\/10.1016\/j.celrep.2024.113865.","journal-title":"Cell Rep"},{"issue":"22","key":"307_CR96","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1080\/10408398.2021.1895064","volume":"62","author":"A Rauf","year":"2022","unstructured":"Rauf A, Khalil AA, Rahman U-u, Khalid A, Naz S, Shariati MA, et al. Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): an updated review. Crit Rev Food Sci Nutr. 2022;62(22):6034\u201354. https:\/\/doi.org\/10.1080\/10408398.2021.1895064.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"10","key":"307_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14(10):648. https:\/\/doi.org\/10.1038\/s41419-023-06154-8.","journal-title":"Cell Death Dis"},{"issue":"2","key":"307_CR98","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/15548627.2024.2403277","volume":"21","author":"Z Sadeghloo","year":"2025","unstructured":"Sadeghloo Z, Nabavi-Rad A, Zali MR, Klionsky DJ, Yadegar A. The interplay between probiotics and host autophagy: mechanisms of action and emerging insights. Autophagy. 2025;21(2):260\u201382. https:\/\/doi.org\/10.1080\/15548627.2024.2403277.","journal-title":"Autophagy"},{"issue":"4","key":"307_CR99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216941120","volume":"120","author":"T Gr\u00fcter","year":"2023","unstructured":"Gr\u00fcter T, Mohamad N, Rilke N, Blusch A, Sgodzai M, Demir S, et al. Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system. Proc Natl Acad Sci U S A. 2023;120(4):e2216941120. https:\/\/doi.org\/10.1073\/pnas.2216941120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"307_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00700-w","volume":"19","author":"ME Bosch","year":"2024","unstructured":"Bosch ME, Dodiya HB, Michalkiewicz J, Lee C, Shaik SM, Weigle IQ, et al. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner. Mol Neurodegener. 2024;19(1):18. https:\/\/doi.org\/10.1186\/s13024-023-00700-w.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"307_CR101","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2206504","volume":"15","author":"TK Das","year":"2023","unstructured":"Das TK, Ganesh BP. Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer\u2019s disease progression. Gut Microbes. 2023;15(1):2206504. https:\/\/doi.org\/10.1080\/19490976.2023.2206504.","journal-title":"Gut Microbes"},{"issue":"1","key":"307_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00635-2","volume":"18","author":"S Chandra","year":"2023","unstructured":"Chandra S, Di Meco A, Dodiya HB, Popovic J, Cuddy LK, Weigle IQ, et al. The gut microbiome regulates astrocyte reaction to A\u03b2 amyloidosis through microglial dependent and independent mechanisms. Mol Neurodegener. 2023;18(1):45. https:\/\/doi.org\/10.1186\/s13024-023-00635-2.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"307_CR103","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012;48(4):612\u201326. https:\/\/doi.org\/10.1016\/j.molcel.2012.08.033.","journal-title":"Mol Cell"},{"issue":"6","key":"307_CR104","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1101\/gr.5540007","volume":"17","author":"A Rada-Iglesias","year":"2007","unstructured":"Rada-Iglesias A, Enroth S, Ameur A, Koch CM, Clelland GK, Respuela-Alonso P, et al. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. Genome Res. 2007;17(6):708\u201319. https:\/\/doi.org\/10.1101\/gr.5540007.","journal-title":"Genome Res"},{"issue":"6","key":"307_CR105","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.molcel.2012.08.033","volume":"14","author":"ME Walsh","year":"2015","unstructured":"Walsh ME, Bhattacharya A, Sataranatarajan K, Qaisar R, Sloane L, Rahman MM, et al. The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging. Aging Cell. 2015;14(6):957\u201370. https:\/\/doi.org\/10.1016\/j.molcel.2012.08.033.","journal-title":"Aging Cell"},{"issue":"22","key":"307_CR106","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112012","volume":"41","author":"M Wang","year":"2022","unstructured":"Wang M, Chen Z, Zhang Y. CBP\/p300 and HDAC activities regulate H3K27 acetylation dynamics and zygotic genome activation in mouse preimplantation embryos. EMBO J. 2022;41(22):e112012. https:\/\/doi.org\/10.15252\/embj.2022112012.","journal-title":"EMBO J"},{"key":"307_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105082","volume":"160","author":"L Yu","year":"2020","unstructured":"Yu L, Zhong X, He Y, Shi Y. Butyrate, but not propionate, reverses maternal diet-induced neurocognitive deficits in offspring. Pharmacol Res. 2020;160:105082. https:\/\/doi.org\/10.1016\/j.phrs.2020.105082.","journal-title":"Pharmacol Res"},{"issue":"7780","key":"307_CR108","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41586-019-1700-7","volume":"574","author":"P Mews","year":"2019","unstructured":"Mews P, Egervari G, Nativio R, Sidoli S, Donahue G, Lombroso S, et al. Alcohol metabolism contributes to brain histone acetylation. Nature. 2019;574(7780):717\u201321. https:\/\/doi.org\/10.1038\/s41586-019-1700-7.","journal-title":"Nature"},{"issue":"1","key":"307_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02878-8","volume":"21","author":"S Xu","year":"2023","unstructured":"Xu S, Li X, Zhang S, Qi C, Zhang Z, Ma R, et al. Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn\u2019s disease: a multi-omics Mendelian randomization study. BMC Med. 2023;21(1):179. https:\/\/doi.org\/10.1186\/s12916-023-02878-8.","journal-title":"BMC Med"},{"key":"307_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106355","volume":"182","author":"W Guo","year":"2022","unstructured":"Guo W, Zhang Z, Li L, Liang X, Wu Y, Wang X, et al. Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes. Pharmacol Res. 2022;182:106355. https:\/\/doi.org\/10.1016\/j.phrs.2022.106355.","journal-title":"Pharmacol Res"},{"issue":"1","key":"307_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-021-00231-6","volume":"7","author":"F Chen","year":"2021","unstructured":"Chen F, Chen Z, Chen M, Chen G, Huang Q, Yang X, et al. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients. NPJ Biofilms Microbiomes. 2021;7(1):60. https:\/\/doi.org\/10.1038\/s41522-021-00231-6.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"307_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1667-1","volume":"17","author":"N Celarain","year":"2020","unstructured":"Celarain N, Tomas-Roig J. Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients. J Neuroinflammation. 2020;17(1):21. https:\/\/doi.org\/10.1186\/s12974-019-1667-1.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"307_CR113","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/s41467-021-21917-7","volume":"12","author":"H Jeong","year":"2021","unstructured":"Jeong H, Mendizabal I, Berto S, Chatterjee P, Layman T, Usui N, et al. Evolution of DNA methylation in the human brain. Nat Commun. 2021;12(1):2021. https:\/\/doi.org\/10.1038\/s41467-021-21917-7.","journal-title":"Nat Commun"},{"issue":"1","key":"307_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01311-9","volume":"15","author":"X Wang","year":"2023","unstructured":"Wang X, Liu L, Jiang X, Saredy J, Xi H, Cueto R, et al. Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer\u2019s disease. Alzheimers Res Ther. 2023;15(1):164. https:\/\/doi.org\/10.1186\/s13195-023-01311-9.","journal-title":"Alzheimers Res Ther"},{"key":"307_CR115","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.molmet.2018.03.016","volume":"12","author":"KL Egerod","year":"2018","unstructured":"Egerod KL, Petersen N, Timshel PN, Rekling JC, Wang Y, Liu Q, et al. Profiling of G protein-coupled receptors in vagal afferents reveals novel gut-to-brain sensing mechanisms. Mol Metab. 2018;12:62\u201375. https:\/\/doi.org\/10.1016\/j.molmet.2018.03.016.","journal-title":"Mol Metab"},{"issue":"637","key":"307_CR116","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl7634","volume":"14","author":"M Moutinho","year":"2022","unstructured":"Moutinho M, Puntambekar SS, Tsai AP, Coronel I, Lin PB, Casali BT, et al. The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14(637):eabl7634. https:\/\/doi.org\/10.1126\/scitranslmed.abl7634.","journal-title":"Sci Transl Med"},{"issue":"1","key":"307_CR117","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2414796","volume":"16","author":"M Yu","year":"2024","unstructured":"Yu M, Yu B, Chen D. The effects of gut microbiota on appetite regulation and the underlying mechanisms. Gut Microbes. 2024;16(1):2414796. https:\/\/doi.org\/10.1080\/19490976.2024.2414796.","journal-title":"Gut Microbes"},{"issue":"1","key":"307_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-023-01053-z","volume":"13","author":"C Xing","year":"2023","unstructured":"Xing C, Huang X, Wang D, Yu D, Hou S, Cui H, et al. Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. Cell Biosci. 2023;13(1):106. https:\/\/doi.org\/10.1186\/s13578-023-01053-z.","journal-title":"Cell Biosci"},{"issue":"1","key":"307_CR119","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12974-015-0239-2","volume":"12","author":"G Santoni","year":"2015","unstructured":"Santoni G, Cardinali C, Morelli MB, Santoni M, Nabissi M, Amantini C. Danger-and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons. J Neuroinflammation. 2015;12(1):21. https:\/\/doi.org\/10.1186\/s12974-015-0239-2.","journal-title":"J Neuroinflammation"},{"key":"307_CR120","doi-asserted-by":"publisher","unstructured":"Han H, Yao J, Wu J, Mao S, Pan H, Qv L, et al. Implications of neurogenesis in depression through BDNF: rodent models, regulatory pathways, gut microbiota, and potential therapy. Mol Psychiatry. 2025:1\u201313. https:\/\/doi.org\/10.1038\/s41380-025-03044-7.","DOI":"10.1038\/s41380-025-03044-7"},{"issue":"10","key":"307_CR121","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41589-021-00837-z","volume":"17","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Hu G, Wang MC. Host and microbiota metabolic signals in aging and longevity. Nat Chem Biol. 2021;17(10):1027\u201336. https:\/\/doi.org\/10.1038\/s41589-021-00837-z.","journal-title":"Nat Chem Biol"},{"issue":"10284","key":"307_CR122","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4.","journal-title":"Lancet"},{"issue":"1","key":"307_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9(1):211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3.","journal-title":"Signal Transduct Target Ther"},{"key":"307_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1494-4","volume":"16","author":"F Angelucci","year":"2019","unstructured":"Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and Alzheimer\u2019s disease. J Neuroinflammation. 2019;16:1\u201310. https:\/\/doi.org\/10.1186\/s12974-019-1494-4.","journal-title":"J Neuroinflammation"},{"issue":"20","key":"307_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/nu15204365","volume":"15","author":"FS Heravi","year":"2023","unstructured":"Heravi FS, Naseri K, Hu H. Gut microbiota composition in patients with neurodegenerative disorders (Parkinson\u2019s and Alzheimer\u2019s) and healthy controls: a systematic review. Nutrients. 2023;15(20):4365. https:\/\/doi.org\/10.3390\/nu15204365.","journal-title":"Nutrients"},{"issue":"1","key":"307_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01683-0","volume":"17","author":"H Zhao","year":"2025","unstructured":"Zhao H, Zhou X, Song Y, Zhao W, Sun Z, Zhu J, et al. Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer\u2019s disease continuum. Alzheimers Res Ther. 2025;17(1):36. https:\/\/doi.org\/10.1186\/s13195-025-01683-0.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"307_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01218-5","volume":"15","author":"M Marizzoni","year":"2023","unstructured":"Marizzoni M, Mirabelli P, Mombelli E, Coppola L, Festari C, Lopizzo N, et al. A peripheral signature of Alzheimer\u2019s disease featuring microbiota-gut-brain axis markers. Alzheimers Res Ther. 2023;15(1):101. https:\/\/doi.org\/10.1186\/s13195-023-01218-5.","journal-title":"Alzheimers Res Ther"},{"key":"307_CR128","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60\u20138. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.019.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"307_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0284-2","volume":"13","author":"W Cao","year":"2018","unstructured":"Cao W, Zheng H. Peripheral immune system in aging and Alzheimer\u2019s disease. Mol Neurodegener. 2018;13(1):51. https:\/\/doi.org\/10.1186\/s13024-018-0284-2.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"307_CR130","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/cns.14252","volume":"29","author":"C Gao","year":"2023","unstructured":"Gao C, Li B, He Y, Huang P, Du J, He G, et al. Early changes of fecal short-chain fatty acid levels in patients with mild cognitive impairments. CNS Neurosci Ther. 2023;29(11):3657\u201366. https:\/\/doi.org\/10.1111\/cns.14252.","journal-title":"CNS Neurosci Ther"},{"issue":"11","key":"307_CR131","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, et al. Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71(11):2233\u201352. https:\/\/doi.org\/10.1136\/gutjnl-2021-326269.","journal-title":"Gut"},{"issue":"1","key":"307_CR132","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","volume":"56","author":"DO Seo","year":"2024","unstructured":"Seo DO, Holtzman DM. Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. Exp Mol Med. 2024;56(1):86\u201394. https:\/\/doi.org\/10.1038\/s12276-023-01146-2.","journal-title":"Exp Mol Med"},{"issue":"2","key":"307_CR133","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut. 2020;69(2):283\u201394. https:\/\/doi.org\/10.1136\/gutjnl-2018-317431.","journal-title":"Gut"},{"issue":"1","key":"307_CR134","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200895","volume":"219","author":"HB Dodiya","year":"2021","unstructured":"Dodiya HB, Lutz HL, Weigle IQ, Patel P, Michalkiewicz J, Roman-Santiago CJ, et al. Gut microbiota\u2013driven brain A\u03b2 amyloidosis in mice requires microglia. J Exp Med. 2021;219(1):e20200895. https:\/\/doi.org\/10.1084\/jem.20200895.","journal-title":"J Exp Med"},{"issue":"4","key":"307_CR135","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/med.21653","volume":"40","author":"W Jia","year":"2020","unstructured":"Jia W, Rajani C, Kaddurah-Daouk R, Li H. Expert insights: the potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer\u2019s disease and hepatic encephalopathy. Med Res Rev. 2020;40(4):1496\u2013507. https:\/\/doi.org\/10.1002\/med.21653.","journal-title":"Med Res Rev"},{"issue":"1","key":"307_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00323-z","volume":"11","author":"X Liang","year":"2022","unstructured":"Liang X, Fu Y, Cao W-t, Wang Z, Zhang K, Jiang Z, et al. Gut microbiome, cognitive function and brain structure: a multi-omics integration analysis. Transl Neurodegener. 2022;11(1):49. https:\/\/doi.org\/10.1186\/s40035-022-00323-z.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"307_CR137","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2371950","volume":"16","author":"KA Conn","year":"2024","unstructured":"Conn KA, Borsom EM, Cope EK. Implications of microbe-derived \u0263-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer\u2019s disease. Gut Microbes. 2024;16(1):2371950. https:\/\/doi.org\/10.1080\/19490976.2024.2371950.","journal-title":"Gut Microbes"},{"key":"307_CR138","doi-asserted-by":"publisher","unstructured":"de JR De-Paula V, Forlenza AS, Forlenza OV. Relevance of gutmicrobiota in cognition, behaviour and Alzheimer\u2019s disease. Pharmacol Res. 2018;136:29\u201334. https:\/\/doi.org\/10.1016\/j.phrs.2018.08.014.","DOI":"10.1016\/j.phrs.2018.08.014"},{"issue":"1","key":"307_CR139","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s42004-018-0026-0","volume":"1","author":"S Shaham-Niv","year":"2018","unstructured":"Shaham-Niv S, Rehak P, Zaguri D, Levin A, Adler-Abramovich L, Vukovi\u0107 L, et al. Differential inhibition of metabolite amyloid formation by generic fibrillation-modifying polyphenols. Commun Chem. 2018;1(1):25. https:\/\/doi.org\/10.1038\/s42004-018-0026-0.","journal-title":"Commun Chem"},{"issue":"1","key":"307_CR140","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-020-00194-x","volume":"9","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Tian DY, Wang YJ. Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives. Transl Neurodegener. 2020;9(1):16. https:\/\/doi.org\/10.1186\/s40035-020-00194-x.","journal-title":"Transl Neurodegener"},{"issue":"700","key":"307_CR141","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo2984","volume":"15","author":"AL Ferreiro","year":"2023","unstructured":"Ferreiro AL, Choi J, Ryou J, Newcomer EP, Thompson R, Bollinger RM, et al. Gut microbiome composition may be an indicator of preclinical Alzheimer\u2019s disease. Sci Transl Med. 2023;15(700):eabo2984. https:\/\/doi.org\/10.1126\/scitranslmed.abo2984.","journal-title":"Sci Transl Med"},{"issue":"5","key":"307_CR142","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.30690","volume":"70","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS, Salzman NH, Acharya C, Sterling RK, White MB, Gavis EA, et al. Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial. Hepatology. 2019;70(5):1690\u2013703. https:\/\/doi.org\/10.1002\/hep.30690.","journal-title":"Hepatology"},{"key":"307_CR143","doi-asserted-by":"publisher","unstructured":"Cerna C, Vidal-Herrera N, Silva-Olivares F, \u00c1lvarez D, Gonz\u00e1lez-Arancibia C, Hidalgo M, et al. Fecal Microbiota Transplantation from Young-Trained Donors Improves Cognitive Function in Old Mice Through Modulation of the Gut-Brain Axis. Aging Dis. 2025. https:\/\/doi.org\/10.14336\/AD.2024.1089.","DOI":"10.14336\/AD.2024.1089"},{"issue":"1","key":"307_CR144","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/nu16010016","volume":"16","author":"YC Hsu","year":"2024","unstructured":"Hsu YC, Huang YY, Tsai SY, Kuo YW, Lin JH, Ho HH, et al. Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer\u2019s Dementia: A 12-Week Randomized, Double-Blind Active-Controlled Study. Nutrients. 2024;16(1):16. https:\/\/doi.org\/10.3390\/nu16010016.","journal-title":"Nutrients"},{"issue":"10291","key":"307_CR145","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X.","journal-title":"Lancet"},{"issue":"11","key":"307_CR146","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/brain\/awp234","volume":"132","author":"M Selikhova","year":"2009","unstructured":"Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ. A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain. 2009;132(11):2947\u201357. https:\/\/doi.org\/10.1093\/brain\/awp234.","journal-title":"Brain"},{"issue":"7","key":"307_CR147","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AH Schapira","year":"2017","unstructured":"Schapira AH, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18(7):435\u201350. https:\/\/doi.org\/10.1038\/nrn.2017.62.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"307_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/v13071394","volume":"13","author":"M Beekes","year":"2021","unstructured":"Beekes M. The neural gut-brain axis of pathological protein aggregation in Parkinson\u2019s disease and its counterpart in peroral prion infections. Viruses. 2021;13(7):1394. https:\/\/doi.org\/10.3390\/v13071394.","journal-title":"Viruses"},{"issue":"2","key":"307_CR149","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"307_CR150","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord. 2015;30(3):350\u20138. https:\/\/doi.org\/10.1002\/mds.26069.","journal-title":"Mov Disord"},{"key":"307_CR151","doi-asserted-by":"publisher","unstructured":"Berthoud HR, Albaugh VL, Neuhuber WL. Gut-brain communication and obesity: understanding functions of the vagus nerve. J Clin Invest. 2021;131(10). https:\/\/doi.org\/10.1172\/JCI148837.","DOI":"10.1172\/JCI148837"},{"issue":"1","key":"307_CR152","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41522-022-00382-0","volume":"8","author":"S Nie","year":"2022","unstructured":"Nie S, Wang J, Deng Y, Ye Z, Ge Y. Inflammatory microbes and genes as potential biomarkers of Parkinson\u2019s disease. NPJ Biofilms Microbiomes. 2022;8(1):101. https:\/\/doi.org\/10.1038\/s41522-022-00382-0.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"307_CR153","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1524-1","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation. 2019;16(1):129. https:\/\/doi.org\/10.1186\/s12974-019-1524-1.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"307_CR154","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00166-2","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021;7(1):27. https:\/\/doi.org\/10.1038\/s41531-021-00166-2.","journal-title":"NPJ Parkinsons Dis"},{"key":"307_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2025.04.004","author":"X Ma","year":"2025","unstructured":"Ma X, Liu Q, Yang G. The multifaceted roles of Akkermansia muciniphila in neurological disorders. Trends Neurosci. 2025. https:\/\/doi.org\/10.1016\/j.tins.2025.04.004.","journal-title":"Trends Neurosci"},{"issue":"10","key":"307_CR156","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00674-y","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022;19(10):625\u201337. https:\/\/doi.org\/10.1038\/s41575-022-00674-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"307_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/nu10060708","volume":"10","author":"S Gerhardt","year":"2018","unstructured":"Gerhardt S, Mohajeri MH. Changes of colonic bacterial composition in Parkinson\u2019s disease and other neurodegenerative diseases. Nutrients. 2018;10(6):708. https:\/\/doi.org\/10.3390\/nu10060708.","journal-title":"Nutrients"},{"issue":"2","key":"307_CR158","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/gutjnl-2020-321654","volume":"70","author":"HS Lee","year":"2021","unstructured":"Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson\u2019s disease: common pathophysiological links. Gut. 2021;70(2):408\u201317. https:\/\/doi.org\/10.1136\/gutjnl-2020-321654.","journal-title":"Gut"},{"issue":"1","key":"307_CR159","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12974-018-1339-6","volume":"15","author":"C Starhof","year":"2018","unstructured":"Starhof C, Winge K, Heegaard N, Skogstrand K, Friis S, Hejl A. Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes. J Neuroinflammation. 2018;15(1):305. https:\/\/doi.org\/10.1186\/s12974-018-1339-6.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"307_CR160","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41575-020-0330-0","volume":"17","author":"RA Travagli","year":"2020","unstructured":"Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2020;17(11):673\u201385. https:\/\/doi.org\/10.1038\/s41575-020-0330-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"307_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, et al. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J Neuroinflammation. 2018;15(1):205. https:\/\/doi.org\/10.1186\/s12974-018-1248-8.","journal-title":"J Neuroinflammation"},{"key":"307_CR162","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.mib.2017.03.004","volume":"35","author":"P Schnupf","year":"2017","unstructured":"Schnupf P, Gaboriau-Routhiau V, Sansonetti PJ, Cerf-Bensussan N. Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world. Curr Opin Microbiol. 2017;35:100\u20139. https:\/\/doi.org\/10.1016\/j.mib.2017.03.004.","journal-title":"Curr Opin Microbiol"},{"issue":"9","key":"307_CR163","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, et al. Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov Disord. 2020;35(9):1626\u201335. https:\/\/doi.org\/10.1002\/mds.28119.","journal-title":"Mov Disord"},{"issue":"2","key":"307_CR164","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/mds.26421","volume":"31","author":"H McCann","year":"2016","unstructured":"McCann H, Cartwright H, Halliday GM. Neuropathology of \u03b1-synuclein propagation and braak hypothesis. Mov Disord. 2016;31(2):152\u201360. https:\/\/doi.org\/10.1002\/mds.26421.","journal-title":"Mov Disord"},{"issue":"1","key":"307_CR165","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01190-2","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9(1):226. https:\/\/doi.org\/10.1186\/s40168-021-01190-2.","journal-title":"Microbiome"},{"issue":"1","key":"307_CR166","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41419-022-05502-0","volume":"14","author":"Z Yang","year":"2023","unstructured":"Yang Z, Wang Y, Wei M, Li S, Jia C, Cheng C, et al. Intrastriatal injection of Parkinson\u2019s disease intestine and vagus lysates initiates \u03b1-synucleinopathy in rat brain. Cell Death Dis. 2023;14(1):4. https:\/\/doi.org\/10.1038\/s41419-022-05502-0.","journal-title":"Cell Death Dis"},{"issue":"8","key":"307_CR167","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00693-y","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan AH, Lim SY, Lang AE. The microbiome\u2013gut\u2013brain axis in Parkinson disease\u2014from basic research to the clinic. Nat Rev Neurol. 2022;18(8):476\u201395. https:\/\/doi.org\/10.1038\/s41582-022-00693-y.","journal-title":"Nat Rev Neurol"},{"issue":"6445","key":"307_CR168","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.364.6445.1030","volume":"364","author":"C O\u2019Neill","year":"2019","unstructured":"O\u2019Neill C. Gut microbes metabolize Parkinson\u2019s disease drug. Science. 2019;364(6445):1030\u20131. https:\/\/doi.org\/10.1126\/science.364.6445.1030.","journal-title":"Science"},{"issue":"6445","key":"307_CR169","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6323","volume":"364","author":"V Maini Rekdal","year":"2019","unstructured":"Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019;364(6445):eaau6323. https:\/\/doi.org\/10.1126\/science.aau6323.","journal-title":"Science"},{"key":"307_CR170","doi-asserted-by":"publisher","unstructured":"Shao X, Wu T, Li M, Zheng M, Lin H, Qi X. Enterococcus faecalis Exerts Neuroprotective Effects via the Vagus Nerve in a Mouse Model of Parkinson\u2019s Disease. Mol Neurobiol. 2025:1\u201317. https:\/\/doi.org\/10.1007\/s12035-025-04052-5.","DOI":"10.1007\/s12035-025-04052-5"},{"key":"307_CR171","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cej.2015.12.015","volume":"288","author":"C Ha","year":"2016","unstructured":"Ha C, Zhu N, Shang R, Shi C, Cui J, Sohoo I, et al. Biorecovery of palladium as nanoparticles by Enterococcus faecalis and its catalysis for chromate reduction. Chem Eng J. 2016;288:246\u201354. https:\/\/doi.org\/10.1016\/j.cej.2015.12.015.","journal-title":"Chem Eng J"},{"key":"307_CR172","doi-asserted-by":"publisher","unstructured":"van Kessel SP, Bullock A, van DijkG, El AidyS. Parkinson\u2019s disease medication alters small intestinal motility and microbiota composition in healthy rats. Msystems. 2022;7(1):e01191\u201321. https:\/\/doi.org\/10.1128\/msystems.01191-21.","DOI":"10.1128\/msystems.01191-21"},{"issue":"5","key":"307_CR173","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020;180(5):862\u2013877.e22. https:\/\/doi.org\/10.1016\/j.cell.2020.02.016.","journal-title":"Cell"},{"issue":"8","key":"307_CR174","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.27390","volume":"33","author":"MC Phillips","year":"2018","unstructured":"Phillips MC, Murtagh DK, Gilbertson LJ, Asztely FJ, Lynch CD. Low-fat versus ketogenic diet in Parkinson\u2019s disease: a pilot randomized controlled trial. Mov Disord. 2018;33(8):1306\u201314. https:\/\/doi.org\/10.1002\/mds.27390.","journal-title":"Mov Disord"},{"issue":"9","key":"307_CR175","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jamaneurol.2024.2305","volume":"81","author":"F Scheperjans","year":"2024","unstructured":"Scheperjans F, Levo R, Bosch B, L\u00e4\u00e4peri M, Pereira PA, Smolander O-P, et al. Fecal microbiota transplantation for treatment of Parkinson disease: a randomized clinical trial. JAMA Neurol. 2024;81(9):925\u201338. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2305.","journal-title":"JAMA Neurol"},{"key":"307_CR176","doi-asserted-by":"publisher","unstructured":"Tan AH, Lim SY, Chong KK, A Manap MAA, Hor JW, Lim JL. Probiotics for constipation in Parkinson disease: a randomized placebo-controlled study. Neurology. 2021;96(5):e772\u2013e782. https:\/\/doi.org\/10.1212\/WNL.0000000000011356.","DOI":"10.1212\/WNL.0000000000011356"},{"issue":"8","key":"307_CR177","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1039\/D3FO00540F","volume":"14","author":"C Chu","year":"2023","unstructured":"Chu C, Yu L, Li Y, Guo H, Zhai Q, Chen W, et al. Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson\u2019s disease. Food Funct. 2023;14(8):3406\u201322. https:\/\/doi.org\/10.1039\/D3FO00540F.","journal-title":"Food Funct"},{"issue":"2","key":"307_CR178","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.parkreldis.2011.09.012","volume":"18","author":"E Pourcher","year":"2012","unstructured":"Pourcher E, Fernandez HH, Stacy M, Mori A, Ballerini R, Chaikin P. Istradefylline for Parkinson\u2019s disease patients experiencing motor fluctuations: results of the KW-6002-US-018 study. Parkinsonism Relat Disord. 2012;18(2):178\u201384. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.09.012.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10130","key":"307_CR179","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(18)30481-1.","journal-title":"Lancet"},{"issue":"10","key":"307_CR180","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(07)70243-0","volume":"6","author":"DH Miller","year":"2007","unstructured":"Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol. 2007;6(10):903\u201312. https:\/\/doi.org\/10.1016\/S1474-4422(07)70243-0.","journal-title":"Lancet Neurol"},{"issue":"supplement_1","key":"307_CR181","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1073\/pnas.1000082107","volume":"108","author":"YK Lee","year":"2011","unstructured":"Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011;108(supplement_1):4615\u201322. https:\/\/doi.org\/10.1073\/pnas.1000082107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR182","doi-asserted-by":"publisher","unstructured":"Cantoni C, Lin Q, Dorsett Y, Ghezzi L, Liu Z, Pan Y.. Alterations of host-gut microbiome interactions in multiple sclerosis. EBioMedicine. 2022;76. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103839.","DOI":"10.1016\/j.ebiom.2022.103839"},{"issue":"1","key":"307_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi S, Gandhi R, Cox LM, Li N, Von Glehn F, Yan R, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7(1):12015. https:\/\/doi.org\/10.1038\/ncomms12015.","journal-title":"Nat Commun"},{"issue":"40","key":"307_CR184","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci U S A. 2017;114(40):10713\u20138. https:\/\/doi.org\/10.1073\/pnas.1711235114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"307_CR185","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s40168-022-01353-w","volume":"10","author":"P Bianchimano","year":"2022","unstructured":"Bianchimano P, Britton GJ, Wallach DS, Smith EM, Cox LM, Liu S, et al. Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis. Microbiome. 2022;10(1):174. https:\/\/doi.org\/10.1186\/s40168-022-01353-w.","journal-title":"Microbiome"},{"key":"307_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.578648","volume":"11","author":"SK Shahi","year":"2020","unstructured":"Shahi SK, Jensen SN, Murra AC, Tang N, Guo H, Gibson-Corley KN, et al. Human commensal Prevotella histicola ameliorates disease as effectively as interferon-beta in the experimental autoimmune encephalomyelitis. Front Immunol. 2020;11:578648. https:\/\/doi.org\/10.3389\/fimmu.2020.578648.","journal-title":"Front Immunol"},{"key":"307_CR187","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138519","author":"SL Pompura","year":"2021","unstructured":"Pompura SL, Wagner A, Kitz A, LaPerche J, Yosef N, Dominguez-Villar M, et al. Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI138519.","journal-title":"J Clin Invest"},{"key":"307_CR188","doi-asserted-by":"publisher","unstructured":"Melbye P, Olsson A, Hansen TH, S\u00f8ndergaard HB, Bang OturaiA. Short\u2010chain fatty acids and gut microbiota in multiple sclerosis. Acta Neurol Scand. 2019;139(3):208\u2013219. https:\/\/doi.org\/10.1111\/ane.13041.","DOI":"10.1111\/ane.13041"},{"key":"307_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.102942","volume":"137","author":"G Wildner","year":"2023","unstructured":"Wildner G. Antigenic mimicry\u2013the key to autoimmunity in immune privileged organs. J Autoimmun. 2023;137:102942. https:\/\/doi.org\/10.1016\/j.jaut.2023.102942.","journal-title":"J Autoimmun"},{"issue":"53","key":"307_CR190","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc7191","volume":"5","author":"AK Pr\u00f6bstel","year":"2020","unstructured":"Pr\u00f6bstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, et al. Gut microbiota\u2013specific IgA+ B cells traffic to the CNS in active multiple sclerosis. Sci Immunol. 2020;5(53):eabc7191. https:\/\/doi.org\/10.1126\/sciimmunol.abc7191.","journal-title":"Sci Immunol"},{"issue":"9","key":"307_CR191","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-022-00677-4","volume":"18","author":"J Correale","year":"2022","unstructured":"Correale J, Hohlfeld R, Baranzini SE. The role of the gut microbiota in multiple sclerosis. Nat Rev Neurol. 2022;18(9):544\u201358. https:\/\/doi.org\/10.1038\/s41582-022-00677-4.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"307_CR192","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000359","volume":"4","author":"V Rothhammer","year":"2017","unstructured":"Rothhammer V, Borucki DM, Garcia Sanchez MI, Mazzola MA, Hemond CC, Regev K, et al. Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS. Neurol Neuroimmunol Neuroinflamm. 2017;4(4):e359. https:\/\/doi.org\/10.1212\/NXI.0000000000000359.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"307_CR193","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000933","volume":"8","author":"T Tsaktanis","year":"2020","unstructured":"Tsaktanis T, Beyer T, Nirschl L, Linnerbauer M, Grummel V, Bussas M, et al. Aryl hydrocarbon receptor plasma agonist activity correlates with disease activity in progressive MS. Neurol Neuroimmunol Neuroinflamm. 2020;8(2):e933. https:\/\/doi.org\/10.1212\/NXI.0000000000000933.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"307_CR194","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s40168-022-01371-z","volume":"10","author":"TL Montgomery","year":"2022","unstructured":"Montgomery TL, Eckstrom K, Lile KH, Caldwell S, Heney ER, Lahue KG, et al. Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity. Microbiome. 2022;10(1):198. https:\/\/doi.org\/10.1186\/s40168-022-01371-z.","journal-title":"Microbiome"},{"key":"307_CR195","unstructured":"Heney ER. Unique Lactobacillus produced metabolites modulate T-cell response through the aryl hydrocarbon receptor: implications for CNS autoimmunity. 2023."},{"issue":"2","key":"307_CR196","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/19490976.2019.1654986","volume":"11","author":"RL Fine","year":"2020","unstructured":"Fine RL, Manfredo Vieira S, Gilmore MS, Kriegel MA. Mechanisms and consequences of gut commensal translocation in chronic diseases. Gut Microbes. 2020;11(2):217\u201330. https:\/\/doi.org\/10.1080\/19490976.2019.1654986.","journal-title":"Gut Microbes"},{"issue":"1","key":"307_CR197","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1038\/s41467-021-25905-8","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, Musco H, Simpson-Yap S, Zhu Z, Wang Y, Lin X, et al. Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases. Nat Commun. 2021;12(1):5641. https:\/\/doi.org\/10.1038\/s41467-021-25905-8.","journal-title":"Nat Commun"},{"key":"307_CR198","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701626","volume":"12","author":"S Haase","year":"2021","unstructured":"Haase S, M\u00e4urer J, Duscha A, Lee DH, Balogh A, Gold R, et al. Propionic acid rescues high-fat diet enhanced immunopathology in autoimmunity via effects on Th17 responses. Front Immunol. 2021;12:701626. https:\/\/doi.org\/10.3389\/fimmu.2021.701626.","journal-title":"Front Immunol"},{"key":"307_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101403","volume":"36","author":"IK Sand","year":"2019","unstructured":"Sand IK, Benn EK, Fabian M, Fitzgerald KC, Digga E, Deshpande R, et al. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: a pilot study. Mult Scler Relat Disord. 2019;36:101403. https:\/\/doi.org\/10.1016\/j.msard.2019.101403.","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"307_CR200","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1039\/D0FO02736K","volume":"12","author":"J Jiang","year":"2021","unstructured":"Jiang J, Chu C, Wu C, Wang C, Zhang C, Li T, et al. Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials. Food Funct. 2021;12(6):2354\u201377. https:\/\/doi.org\/10.1039\/D0FO02736K.","journal-title":"Food Funct"},{"issue":"5","key":"307_CR201","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s10787-023-01248-9","volume":"31","author":"AH Faghfouri","year":"2023","unstructured":"Faghfouri AH, Afrakoti LGMP, Kavyani Z, Nogourani ZS, Musazadeh V, Jafarlou M, et al. The role of probiotic supplementation in inflammatory biomarkers in adults: an umbrella meta-analysis of randomized controlled trials. Inflammopharmacology. 2023;31(5):2253\u201368. https:\/\/doi.org\/10.1007\/s10787-023-01248-9.","journal-title":"Inflammopharmacology"},{"key":"307_CR202","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.901846","volume":"16","author":"M Rahimlou","year":"2022","unstructured":"Rahimlou M, Nematollahi S, Husain D, Banaei-Jahromi N, Majdinasab N, Hosseini SA. Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Front Neurosci. 2022;16:901846. https:\/\/doi.org\/10.3389\/fnins.2022.901846.","journal-title":"Front Neurosci"},{"key":"307_CR203","unstructured":"Novartis AG, An open-label, multi-center, phase I\/II study to assess safety, disease progression, and cellular kinetics following YTB323 administration in participants with non-active Progressive Multiple Sclerosis (PMS). 2024, ClinicalTrials.gov."},{"issue":"2","key":"307_CR204","doi-asserted-by":"publisher","DOI":"10.1177\/20552173221086662","volume":"8","author":"KF Al","year":"2022","unstructured":"Al KF, Craven LJ, Gibbons S, Parvathy SN, Wing AC, Graf C, et al. Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: a pilot randomized controlled trial. Mult Scler J. 2022;8(2):20552173221086662. https:\/\/doi.org\/10.1177\/20552173221086662.","journal-title":"Mult Scler J"},{"key":"307_CR205","doi-asserted-by":"publisher","unstructured":"Tr\u00e4ger C, Kaiser M, Freudenstein D, Heckscher S, Dettmer K, Oefner PJ, et al. A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals. EBioMedicine. 2025;116. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105996.","DOI":"10.1016\/j.ebiom.2024.105996"},{"key":"307_CR206","doi-asserted-by":"publisher","unstructured":"Duscha A, J\u00f6rg S, Berg J, Linker R, Gold R, Haghikia A. The Effect of the orally applied short chain fatty acid propionate on the immune regulation in MS: results of a human proof-of-concept study (P3. 388). Neurology. 2017;88(16_supplement): P3. 388. https:\/\/doi.org\/10.1212\/wnl.88.16_supplement.p3.388.","DOI":"10.1212\/wnl.88.16_supplement.p3.388"},{"issue":"10","key":"307_CR207","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1916945","volume":"383","author":"S Paganoni","year":"2020","unstructured":"Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, et al. Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis. N Engl J Med. 2020;383(10):919\u201330. https:\/\/doi.org\/10.1056\/NEJMoa1916945.","journal-title":"N Engl J Med"},{"key":"307_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.09.011","author":"DC Ladakis","year":"2025","unstructured":"Ladakis DC, Harrison KL, Smith MD, Solem K, Gadani S, Jank L, et al. Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease. Med. 2025. https:\/\/doi.org\/10.1016\/j.medj.2024.09.011.","journal-title":"Med"},{"issue":"10360","key":"307_CR209","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01441-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400(10360):1363\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(22)01441-7.","journal-title":"Lancet"},{"issue":"11","key":"307_CR210","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(07)70265-X","volume":"6","author":"J Phukan","year":"2007","unstructured":"Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6(11):994\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(07)70265-X.","journal-title":"Lancet Neurol"},{"issue":"9","key":"307_CR211","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41582-023-00869-0","volume":"19","author":"A Ludolph","year":"2023","unstructured":"Ludolph A, Dupuis L, Kasarskis E, Steyn F, Ngo S, McDermott C. Nutritional and metabolic factors in amyotrophic lateral sclerosis. Nat Rev Neurol. 2023;19(9):511\u201324. https:\/\/doi.org\/10.1038\/s41582-023-00869-0.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"307_CR212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-021-01997-8","volume":"19","author":"SL Boddy","year":"2021","unstructured":"Boddy SL, Giovannelli I, Sassani M, Cooper-Knock J, Snyder MP, Segal E, et al. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Med. 2021;19(1):1\u201314. https:\/\/doi.org\/10.1186\/s12916-021-01997-8.","journal-title":"BMC Med"},{"issue":"4","key":"307_CR213","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/joim.13339","volume":"290","author":"J Sun","year":"2021","unstructured":"Sun J, Huang T, Debelius JW, Fang F. Gut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence. J Intern Med. 2021;290(4):758\u201388. https:\/\/doi.org\/10.1111\/joim.13339.","journal-title":"J Intern Med"},{"issue":"2","key":"307_CR214","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019;18(2):211\u201320. https:\/\/doi.org\/10.1016\/S1474-4422(18)30394-6.","journal-title":"Lancet Neurol"},{"key":"307_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00441","author":"J Sun","year":"2024","unstructured":"Sun J, Zhang Y. Microbiome and micronutrient in ALS: from novel mechanisms to new treatments. Neurotherapeutics. 2024. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00441.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"307_CR216","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1996848","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ogbu D, Garrett S, Xia Y, Sun J. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis. Gut Microbes. 2021;13(1):1996848. https:\/\/doi.org\/10.1080\/19490976.2021.1996848.","journal-title":"Gut Microbes"},{"issue":"2","key":"307_CR217","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c70009","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Robinson K, Xia Y, Sun J. Synergistic effects of Riluzole and Sodium butyrate on barrier function and disease progression of amyotrophic lateral sclerosis through the gut-neuron axis. Compr Physiol. 2025;15(2):e70009. https:\/\/doi.org\/10.1002\/cphy.c70009.","journal-title":"Compr Physiol"},{"issue":"6","key":"307_CR218","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/bph.15142","volume":"178","author":"J Riancho","year":"2021","unstructured":"Riancho J, Delgado-Alvarado M, Andreu MD, Paz-Fajardo L, Arozamena S, Gil-Bea FJ, et al. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge. Br J Pharmacol. 2021;178(6):1269\u201378. https:\/\/doi.org\/10.1111\/bph.15142.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"307_CR219","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40168-022-01218-8","volume":"10","author":"LM Cox","year":"2022","unstructured":"Cox LM, Calcagno N, Gauthier C, Madore C, Butovsky O, Weiner HL. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome. 2022;10(1):47. https:\/\/doi.org\/10.1186\/s40168-022-01218-8.","journal-title":"Microbiome"},{"issue":"9934","key":"307_CR220","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","volume":"383","author":"AM Wills","year":"2014","unstructured":"Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383(9934):2065\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(14)60222-1.","journal-title":"Lancet"},{"key":"307_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01632-5","volume":"18","author":"D Di Gioia","year":"2020","unstructured":"Di Gioia D, Bozzi Cionci N, Baffoni L, Amoruso A, Pane M, Mogna L, et al. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med. 2020;18:1\u201319. https:\/\/doi.org\/10.1186\/s12916-020-01632-5.","journal-title":"BMC Med"},{"issue":"1","key":"307_CR222","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/nu16010102","volume":"17","author":"F Cuffaro","year":"2024","unstructured":"Cuffaro F, Lamminp\u00e4\u00e4 I, Niccolai E, Amedei A. Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment. Nutrients. 2024;17(1):102. https:\/\/doi.org\/10.3390\/nu16010102.","journal-title":"Nutrients"},{"issue":"1","key":"307_CR223","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03781-6","volume":"22","author":"R Feng","year":"2024","unstructured":"Feng R, Zhu Q, Wang A, Wang H, Wang J, Chen P, et al. Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. BMC Med. 2024;22(1):566. https:\/\/doi.org\/10.1186\/s12916-024-03781-6.","journal-title":"BMC Med"},{"key":"307_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102256","author":"E Zucchi","year":"2023","unstructured":"Zucchi E, Musazzi UM, Fedele G, Martinelli I, Gianferrari G, Simonini C, et al. Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study. EClinicalMedicine. 2023. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102256.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"307_CR225","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00307-z","volume":"11","author":"K Khalaf","year":"2022","unstructured":"Khalaf K, Tornese P, Cocco A, Albanese A. Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases. Transl Neurodegener. 2022;11(1):33. https:\/\/doi.org\/10.1186\/s40035-022-00307-z.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"307_CR226","doi-asserted-by":"publisher","first-page":"23095","DOI":"10.1038\/s41598-024-74400-w","volume":"14","author":"V Andreozzi","year":"2024","unstructured":"Andreozzi V, Cuoco S, Balestrieri M, Fierro F, Ferrara N, Erro R, et al. Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson\u2019s disease: results from an open label single-arm study. Sci Rep. 2024;14(1):23095. https:\/\/doi.org\/10.1038\/s41598-024-74400-w.","journal-title":"Sci Rep"},{"key":"307_CR227","doi-asserted-by":"publisher","unstructured":"Rusch C, Beke M, Nieves JrC, Mai V, Stiep T, Tholanikunnel T. Promotion of a mediterranean diet alters constipation symptoms and fecal calprotectin in people with Parkinson\u2019s disease: a randomized controlled trial. Nutrients. 2024;16(17): 2946. https:\/\/doi.org\/10.3390\/nu16172946.","DOI":"10.3390\/nu16172946"},{"issue":"6","key":"307_CR228","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70351","volume":"21","author":"RA Whitmer","year":"2025","unstructured":"Whitmer RA, Baker LD, Carrillo MC, Snyder HM, Cleveland ML, Gitelman DR, et al. Baseline characteristics of the US study to protect brain health through lifestyle intervention to reduce risk (US POINTER): successful enrollment of a diverse clinical trial cohort at risk for cognitive decline. Alzheimers Dement. 2025;21(6):e70351. https:\/\/doi.org\/10.1002\/alz.70351.","journal-title":"Alzheimers Dement"},{"issue":"5_Part_2","key":"307_CR229","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7326\/0003-4819-139-5_part_2-200309021-00012","volume":"139","author":"MP Mattson","year":"2003","unstructured":"Mattson MP. Gene\u2013diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med. 2003;139(5_Part_2):441\u20134. https:\/\/doi.org\/10.7326\/0003-4819-139-5_part_2-200309021-00012.","journal-title":"Ann Intern Med"},{"issue":"3","key":"307_CR230","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/alz.12421","volume":"18","author":"S Hoscheidt","year":"2022","unstructured":"Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, et al. Mediterranean and Western diet effects on Alzheimer\u2019s disease biomarkers, cerebral perfusion, and cognition in mid-life: a randomized trial. Alzheimers Dement. 2022;18(3):457\u201368. https:\/\/doi.org\/10.1002\/alz.12421.","journal-title":"Alzheimers Dement"},{"key":"307_CR231","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neubiorev.2021.05.031","volume":"128","author":"MD Kendig","year":"2021","unstructured":"Kendig MD, Leigh SJ, Morris MJ. Unravelling the impacts of western-style diets on brain, gut microbiota and cognition. Neurosci Biobehav Rev. 2021;128:233\u201343. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.05.031.","journal-title":"Neurosci Biobehav Rev"},{"issue":"29","key":"307_CR232","doi-asserted-by":"publisher","first-page":"8059","DOI":"10.1080\/10408398.2021.1925220","volume":"62","author":"S Kheirouri","year":"2022","unstructured":"Kheirouri S, Alizadeh M. Mind diet and cognitive performance in older adults: a systematic review. Crit Rev Food Sci Nutr. 2022;62(29):8059\u201377. https:\/\/doi.org\/10.1080\/10408398.2021.1925220.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"307_CR233","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/alz.13521","volume":"20","author":"H Chen","year":"2024","unstructured":"Chen H, Dunk MM, Wang B, Zhao M, Shen J, Zong G, et al. Associations of the Mediterranean-DASH intervention for neurodegenerative delay diet with brain structural markers and their changes. Alzheimers Dement. 2024;20(2):1190\u2013200. https:\/\/doi.org\/10.1002\/alz.13521.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"307_CR234","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/mds.28464","volume":"36","author":"A Metcalfe-Roach","year":"2021","unstructured":"Metcalfe-Roach A, Yu AC, Golz E, Cirstea M, Sundvick K, Kliger D, et al. Mind and Mediterranean diets associated with later onset of Parkinson\u2019s disease. Mov Disord. 2021;36(4):977\u201384. https:\/\/doi.org\/10.1002\/mds.28464.","journal-title":"Mov Disord"},{"issue":"22","key":"307_CR235","doi-asserted-by":"publisher","first-page":"e2259","DOI":"10.1212\/WNL.0000000000207176","volume":"100","author":"P Agarwal","year":"2023","unstructured":"Agarwal P, Leurgans SE, Agrawal S, Aggarwal NT, Cherian LJ, James BD, et al. Association of Mediterranean-DASH intervention for neurodegenerative delay and Mediterranean diets with Alzheimer disease pathology. Neurology. 2023;100(22):e2259\u201368. https:\/\/doi.org\/10.1212\/WNL.0000000000207176.","journal-title":"Neurology"},{"key":"307_CR236","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00105","volume":"7","author":"F Baert","year":"2020","unstructured":"Baert F, Matthys C, Mellaerts R, Lema\u00eetre D, Vlaemynck G, Foulon V. Dietary intake of Parkinson\u2019s disease patients. Front Nutr. 2020;7:105. https:\/\/doi.org\/10.3389\/fnut.2020.00105.","journal-title":"Front Nutr"},{"issue":"2","key":"307_CR237","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tem.2023.10.001","volume":"35","author":"A Paoli","year":"2024","unstructured":"Paoli A, Tinsley GM, Mattson MP, De Vivo I, Dhawan R, Moro T. Common and divergent molecular mechanisms of fasting and ketogenic diets. Trends Endocrinol Metab. 2024;35(2):125\u201341. https:\/\/doi.org\/10.1016\/j.tem.2023.10.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"307_CR238","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tins.2012.11.005","volume":"36","author":"A Lutas","year":"2013","unstructured":"Lutas A, Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 2013;36(1):32\u201340. https:\/\/doi.org\/10.1016\/j.tins.2012.11.005.","journal-title":"Trends Neurosci"},{"key":"307_CR239","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.12923","author":"LD Baker","year":"2025","unstructured":"Baker LD, Espeland MA, Whitmer RA, Snyder HM, Leng X, Lovato L, et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: the US pointer randomized clinical trial. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.12923.","journal-title":"JAMA"},{"issue":"7973","key":"307_CR240","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-023-06378-w","volume":"620","author":"MT Khan","year":"2023","unstructured":"Khan MT, Dwibedi C, Sundh D, Pradhan M, Kraft JD, Caesar R, et al. Synergy and oxygen adaptation for development of next-generation probiotics. Nature. 2023;620(7973):381\u20135. https:\/\/doi.org\/10.1038\/s41586-023-06378-w.","journal-title":"Nature"},{"key":"307_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135949","volume":"756","author":"S Shamsipour","year":"2021","unstructured":"Shamsipour S, Sharifi G, Taghian F. Impact of interval training with probiotic (L. plantarum\/Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer\u2019s disease. Neurosci Lett. 2021;756:135949. https:\/\/doi.org\/10.1016\/j.neulet.2021.135949.","journal-title":"Neurosci Lett"},{"issue":"10","key":"307_CR242","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopsych.2013.05.001","volume":"74","author":"TG Dinan","year":"2013","unstructured":"Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720\u20136. https:\/\/doi.org\/10.1016\/j.biopsych.2013.05.001.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"307_CR243","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1080\/10408398.2017.1399860","volume":"59","author":"S Misra","year":"2019","unstructured":"Misra S, Mohanty D. Psychobiotics: a new approach for treating mental illness? Crit Rev Food Sci Nutr. 2019;59(8):1230\u20136. https:\/\/doi.org\/10.1080\/10408398.2017.1399860.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"11","key":"307_CR244","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.tins.2016.09.002","volume":"39","author":"A Sarkar","year":"2016","unstructured":"Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PW. Psychobiotics and the manipulation of bacteria\u2013gut\u2013brain signals. Trends Neurosci. 2016;39(11):763\u201381. https:\/\/doi.org\/10.1016\/j.tins.2016.09.002.","journal-title":"Trends Neurosci"},{"issue":"11","key":"307_CR245","doi-asserted-by":"publisher","first-page":"e939","DOI":"10.1038\/tp.2016.191","volume":"6","author":"AP Allen","year":"2016","unstructured":"Allen AP, Hutch W, Borre YE, Kennedy PJ, Temko A, Boylan G, et al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry. 2016;6(11):e939\u2013e939. https:\/\/doi.org\/10.1038\/tp.2016.191.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"307_CR246","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00327-6","volume":"8","author":"H Sun","year":"2022","unstructured":"Sun H, Zhao F, Liu Y, Ma T, Jin H, Quan K, et al. Probiotics synergized with conventional regimen in managing Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8(1):62. https:\/\/doi.org\/10.1038\/s41531-022-00327-6.","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"307_CR247","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.18632\/aging.102810","volume":"12","author":"H Den","year":"2020","unstructured":"Den H, Dong X, Chen M, Zou Z. Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer\u2019s disease or mild cognitive impairment - a meta-analysis of randomized controlled trials. Aging. 2020;12(4):4010\u201339. https:\/\/doi.org\/10.18632\/aging.102810.","journal-title":"Aging"},{"issue":"2","key":"307_CR248","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","volume":"9","author":"TJ Borody","year":"2012","unstructured":"Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2012;9(2):88\u201396. https:\/\/doi.org\/10.1038\/nrgastro.2011.244.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"307_CR249","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-med-111717-122956","volume":"70","author":"RE Ooijevaar","year":"2019","unstructured":"Ooijevaar RE, Terveer EM, Verspaget HW, Kuijper EJ, Keller JJ. Clinical application and potential of fecal microbiota transplantation. Annu Rev Med. 2019;70(1):335\u201351. https:\/\/doi.org\/10.1146\/annurev-med-111717-122956.","journal-title":"Annu Rev Med"},{"key":"307_CR250","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ebiom.2019.05.066","volume":"44","author":"K Wortelboer","year":"2019","unstructured":"Wortelboer K, Nieuwdorp M, Herrema H. Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine. 2019;44:716\u201329. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.066.","journal-title":"EBioMedicine"},{"issue":"1","key":"307_CR251","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41575-020-0340-5","volume":"18","author":"A Khoruts","year":"2021","unstructured":"Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol. 2021;18(1):67\u201380. https:\/\/doi.org\/10.1038\/s41575-020-0340-5.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"307_CR252","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1080\/03007995.2021.1957807","volume":"37","author":"SH Park","year":"2021","unstructured":"Park SH, Lee JH, Shin J, Kim JS, Cha B, Lee S, et al. Cognitive function improvement after fecal microbiota transplantation in Alzheimer\u2019s dementia patient: a case report. Curr Med Res Opin. 2021;37(10):1739\u201344. https:\/\/doi.org\/10.1080\/03007995.2021.1957807.","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"307_CR253","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jamaneurol.2024.2293","volume":"81","author":"TR Sampson","year":"2024","unstructured":"Sampson TR. Fecal microbiome transplants for Parkinson disease. JAMA Neurol. 2024;81(9):911\u20133. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2293.","journal-title":"JAMA Neurol"},{"issue":"10","key":"307_CR254","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-071766","volume":"13","author":"KE Vendrik","year":"2023","unstructured":"Vendrik KE, Chernova VO, Kuijper EJ, Terveer EM, van Hilten JJ, Contarino MF. Safety and feasibility of faecal microbiota transplantation for patients with Parkinson\u2019s disease: a protocol for a self-controlled interventional donor-FMT pilot study. BMJ Open. 2023;13(10):e071766. https:\/\/doi.org\/10.1136\/bmjopen-2023-071766.","journal-title":"BMJ Open"},{"issue":"4","key":"307_CR255","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4236\/ojgas.2017.74015","volume":"7","author":"T Thurm","year":"2017","unstructured":"Thurm T, Ablin J, Buskila D, Maharshak N. Fecal microbiota transplantation for fibromyalgia: a case report and review of the literature. Open J Gastroenterol. 2017;7(4):131\u20139. https:\/\/doi.org\/10.4236\/ojgas.2017.74015.","journal-title":"Open J Gastroenterol"},{"issue":"1","key":"307_CR256","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2412376","volume":"16","author":"DY Kim","year":"2024","unstructured":"Kim DY, Lee SY, Lee JY, Whon TW, Lee JY, Jeon CO, et al. Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products. Gut Microbes. 2024;16(1):2412376. https:\/\/doi.org\/10.1080\/19490976.2024.2412376.","journal-title":"Gut Microbes"},{"issue":"2","key":"307_CR257","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.chom.2020.01.018","volume":"27","author":"PE Carlson","year":"2020","unstructured":"Carlson PE. Regulatory considerations for fecal microbiota transplantation products. Cell Host Microbe. 2020;27(2):173\u20135. https:\/\/doi.org\/10.1016\/j.chom.2020.01.018.","journal-title":"Cell Host Microbe"},{"issue":"12","key":"307_CR258","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","volume":"71","author":"S Kedia","year":"2022","unstructured":"Kedia S, Virmani S, Vuyyuru SK, Kumar P, Kante B, Sahu P, et al. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut. 2022;71(12):2401\u201313. https:\/\/doi.org\/10.1136\/gutjnl-2022-327811.","journal-title":"Gut"},{"issue":"7","key":"307_CR259","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/gutjnl-2012-302021","volume":"61","author":"K Tsilingiri","year":"2012","unstructured":"Tsilingiri K, Barbosa T, Penna G, Caprioli F, Sonzogni A, Viale G, et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut. 2012;61(7):1007\u201315. https:\/\/doi.org\/10.1136\/gutjnl-2012-302021.","journal-title":"Gut"},{"key":"307_CR260","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.phrs.2015.11.026","volume":"103","author":"R Russo","year":"2016","unstructured":"Russo R, De Caro C, Avagliano C, Cristiano C, La Rana G, Raso GM, et al. Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice. Pharmacol Res. 2016;103:279\u201391. https:\/\/doi.org\/10.1016\/j.phrs.2015.11.026.","journal-title":"Pharmacol Res"},{"key":"307_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100246","author":"I Levi","year":"2021","unstructured":"Levi I, Gurevich M, Perlman G, Magalashvili D, Menascu S, Bar N, et al. Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis. Cell Rep Med. 2021. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100246.","journal-title":"Cell Rep Med"},{"issue":"1","key":"307_CR262","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00213-021-06025-0","volume":"239","author":"C Wang","year":"2022","unstructured":"Wang C, Zheng D, Weng F, Jin Y, He L. Sodium butyrate ameliorates the cognitive impairment of Alzheimer\u2019s disease by regulating the metabolism of astrocytes. Psychopharmacology. 2022;239(1):215\u201327. https:\/\/doi.org\/10.1007\/s00213-021-06025-0.","journal-title":"Psychopharmacology"},{"issue":"12","key":"307_CR263","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1177\/0963689719873890","volume":"28","author":"G Schepici","year":"2019","unstructured":"Schepici G, Silvestro S, Bramanti P, Mazzon E. The gut microbiota in multiple sclerosis: an overview of clinical trials. Cell Transplant. 2019;28(12):1507\u201327. https:\/\/doi.org\/10.1177\/0963689719873890.","journal-title":"Cell Transplant"},{"issue":"22","key":"307_CR264","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1177\/0963689719873890","volume":"16","author":"L Lorefice","year":"2024","unstructured":"Lorefice L, Zoledziewska M. Propionic Acid Impact on Multiple Sclerosis: Evidence and Challenges. Nutrients. 2024;16(22):3887. https:\/\/doi.org\/10.1177\/0963689719873890.","journal-title":"Nutrients"},{"issue":"6","key":"307_CR265","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.clnu.2023.04.001","volume":"42","author":"CS Kim","year":"2023","unstructured":"Kim CS, Jung S, Hwang GS, Shin DM. Gut microbiota indole-3-propionic acid mediates neuroprotective effect of probiotic consumption in healthy elderly: a randomized, double-blind, placebo-controlled, multicenter trial and in vitro study. Clin Nutr. 2023;42(6):1025\u201333. https:\/\/doi.org\/10.1016\/j.clnu.2023.04.001.","journal-title":"Clin Nutr"},{"issue":"19","key":"307_CR266","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1080\/10408398.2020.1793728","volume":"61","author":"V Stacchiotti","year":"2021","unstructured":"Stacchiotti V, Rezzi S, Eggersdorfer M, Galli F. Metabolic and functional interplay between gut microbiota and fat-soluble vitamins. Crit Rev Food Sci Nutr. 2021;61(19):3211\u201332. https:\/\/doi.org\/10.1080\/10408398.2020.1793728.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"307_CR267","doi-asserted-by":"publisher","first-page":"e00301","DOI":"10.1016\/j.neurot.2023.10.011","volume":"21","author":"R L\u00f3pez-Blanch","year":"2024","unstructured":"L\u00f3pez-Blanch R, Salvador-Palmer R, Oriol-Caballo M, Moreno-Murciano P, Dellinger RW, Estrela JM, et al. Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS mice. Neurotherapeutics. 2024;21(1):e00301. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.011.","journal-title":"Neurotherapeutics"},{"issue":"7","key":"307_CR268","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.molmed.2021.04.009","volume":"27","author":"D D\u2019Amico","year":"2021","unstructured":"D\u2019Amico D, Andreux PA, Vald\u00e9s P, Singh A, Rinsch C, Auwerx J. Impact of the natural compound urolithin A on health, disease, and aging. Trends Mol Med. 2021;27(7):687\u201399. https:\/\/doi.org\/10.1016\/j.molmed.2021.04.009.","journal-title":"Trends Mol Med"},{"issue":"1","key":"307_CR269","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.molmed.2021.04.009","volume":"28","author":"HJ Lee","year":"2021","unstructured":"Lee HJ, Jung YH, Choi GE, Kim JS, Chae CW, Lim JR, et al. Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis. Cell Death Differ. 2021;28(1):184\u2013202. https:\/\/doi.org\/10.1016\/j.molmed.2021.04.009.","journal-title":"Cell Death Differ"},{"key":"307_CR270","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119252","volume":"272","author":"L Zangerolamo","year":"2021","unstructured":"Zangerolamo L, Vettorazzi JF, Rosa LR, Carneiro EM, Barbosa HC. The bile acid TUDCA and neurodegenerative disorders: an overview. Life Sci. 2021;272:119252. https:\/\/doi.org\/10.1016\/j.lfs.2021.119252.","journal-title":"Life Sci"},{"key":"307_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108341","volume":"78","author":"G Wang","year":"2020","unstructured":"Wang G, Kong B, Shuai W, Fu H, Jiang X, Huang H. 3, 3-dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice. J Nutr Biochem. 2020;78:108341. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108341.","journal-title":"J Nutr Biochem"},{"issue":"9","key":"307_CR272","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093041","volume":"13","author":"CN Hsu","year":"2021","unstructured":"Hsu CN, Hou CY, Lee T, Chang-Chien G-P, Lin S, Tain YL. Maternal 3, 3-dimethyl-1-butanol therapy protects adult male rat offspring against hypertension programmed by perinatal TCDD exposure. Nutrients. 2021;13(9):3041. https:\/\/doi.org\/10.3390\/nu13093041.","journal-title":"Nutrients"},{"key":"307_CR273","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0451-2","volume":"10","author":"NM Vogt","year":"2018","unstructured":"Vogt NM, Romano KA, Darst BF, Engelman CD, Johnson SC, Carlsson CM, et al. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease. Alzheimers Res Ther. 2018;10:1\u20138. https:\/\/doi.org\/10.1186\/s13195-018-0451-2.","journal-title":"Alzheimers Res Ther"},{"issue":"22","key":"307_CR274","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223650","volume":"11","author":"Y Deng","year":"2022","unstructured":"Deng Y, Zou J, Hong Y, Peng Q, Fu X, Duan R, et al. Higher circulating trimethylamine N-oxide aggravates cognitive impairment probably via downregulating hippocampal SIRT1 in vascular dementia rats. Cells. 2022;11(22):3650. https:\/\/doi.org\/10.3390\/cells11223650.","journal-title":"Cells"},{"key":"307_CR275","doi-asserted-by":"publisher","DOI":"10.1172\/jci187996","author":"MK Kim","year":"2025","unstructured":"Kim MK, Suh GA, Cullen GD, Rodriguez SP, Dharmaraj T, Chang THW, et al. Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/jci187996.","journal-title":"J Clin Invest"},{"issue":"6","key":"307_CR276","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1101\/2023.08.28.23294728","volume":"9","author":"JP Pirnay","year":"2024","unstructured":"Pirnay JP, Djebara S, Steurs G, Griselain J, Cochez C, De Soir S, et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat Microbiol. 2024;9(6):1434\u201353. https:\/\/doi.org\/10.1101\/2023.08.28.23294728.","journal-title":"Nat Microbiol"},{"issue":"1","key":"307_CR277","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77038-w","volume":"14","author":"JP Hong","year":"2024","unstructured":"Hong JP, Shin S, Chung SH, Song MC, Shim JG, Kim Y, et al. Bacteriophages targeting Enterococcus faecalis enhance the therapeutic efficacy of levodopa in an MPTP-induced Parkinson\u2019s disease mouse model with E. faecalis gut colonization. Sci Rep. 2024;14(1):26146. https:\/\/doi.org\/10.1038\/s41598-024-77038-w.","journal-title":"Sci Rep"},{"issue":"15","key":"307_CR278","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158281","volume":"23","author":"N Li","year":"2022","unstructured":"Li N, Zhou T, Fei E. Actions of metformin in the brain: a new perspective of metformin treatments in related neurological disorders. Int J Mol Sci. 2022;23(15):8281. https:\/\/doi.org\/10.3390\/ijms23158281.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"307_CR279","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/neuonc\/noab131","volume":"23","author":"N Yuen","year":"2021","unstructured":"Yuen N, Szulc-Lerch KU, Li YQ, Morshead CM, Mabbott DJ, Wong CS, et al. Metformin effects on brain development following cranial irradiation in a mouse model. Neuro Oncol. 2021;23(9):1523\u201336. https:\/\/doi.org\/10.1093\/neuonc\/noab131.","journal-title":"Neuro Oncol"},{"issue":"6","key":"307_CR280","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1007\/s13311-023-01426-9","volume":"20","author":"PJ Bergold","year":"2023","unstructured":"Bergold PJ, Furhang R, Lawless S. Treating traumatic brain injury with minocycline. Neurotherapeutics. 2023;20(6):1546\u201364. https:\/\/doi.org\/10.1007\/s13311-023-01426-9.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"307_CR281","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7150\/ijbs.64187","volume":"18","author":"Q Lu","year":"2022","unstructured":"Lu Q, Xiong J, Yuan Y, Ruan Z, Zhang Y, Chai B, et al. Minocycline improves the functional recovery after traumatic brain injury via inhibition of aquaporin-4. Int J Biol Sci. 2022;18(1):441. https:\/\/doi.org\/10.7150\/ijbs.64187.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"307_CR282","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1002\/alz.13830","volume":"20","author":"RB Brown","year":"2024","unstructured":"Brown RB, Tozer DJ, Loubi\u00e8re L, Harshfield EL, Hong YT, Fryer TD, et al. MINocyclinE to reduce inflammation and blood-brain barrier leakage in small vessel diseAse (MINERVA): a phase II, randomized, double-blind, placebo-controlled experimental medicine trial. Alzheimers Dement. 2024;20(6):3852\u201363. https:\/\/doi.org\/10.1002\/alz.13830.","journal-title":"Alzheimers Dement"},{"key":"307_CR283","doi-asserted-by":"publisher","unstructured":"Cabanillas-Lazo M, Pascual-Guevara M, Mamani-Garcia CS, Velasquez-Rimachi V, Mori N and Alva-Diaz C. Effects of probiotic, prebiotic or synbiotic supplementation on Parkinson\u2019s disease: a systematic review with meta-analysis (P13\u201311.003). Neurology. 2022; 98(18_supplement): 2048. https:\/\/doi.org\/10.1212\/wnl.98.18_supplement.2048.","DOI":"10.1212\/wnl.98.18_supplement.2048"},{"issue":"11","key":"307_CR284","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.clnu.2022.09.012","volume":"41","author":"MR Aljumaah","year":"2022","unstructured":"Aljumaah MR, Bhatia U, Roach J, Gunstad J, Peril MAA. The gut microbiome, mild cognitive impairment, and probiotics: a randomized clinical trial in middle-aged and older adults. Clin Nutr. 2022;41(11):2565\u201376. https:\/\/doi.org\/10.1016\/j.clnu.2022.09.012.","journal-title":"Clin Nutr"},{"issue":"1","key":"307_CR285","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54553-4","volume":"14","author":"Y Ye","year":"2024","unstructured":"Ye Y, Tong HYK, Chong WH, Li Z, Tam PKH, Baptista-Hon DT, et al. A systematic review and meta-analysis of the effects of long-term antibiotic use on cognitive outcomes. Sci Rep. 2024;14(1):4026. https:\/\/doi.org\/10.1038\/s41598-024-54553-4.","journal-title":"Sci Rep"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00307-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00307-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00307-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T19:01:54Z","timestamp":1757962914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00307-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":285,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00307-1","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}